The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical Nonparametric Statistics
Groggel, D. J. (2000) · Technometrics · doi:10.1080/00401706.2000.10486067 · Cited by 11,041
Advances in the Study of Behavior
(1998) · Advances in the Study of Behavior · doi:10.1016/s0065-3454(13)60001-7 · Cited by 1,741
Practical Nonparametric Statistics.
Sen, P. K., & Conover, W. J. (1972) · Journal of the American Statistical Association · doi:10.2307/2284744 · Cited by 993
U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
Vonvoigtlander, P. F., Lahti, R. A., & Ludens, J. H. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33422-1 · Cited by 805
Drug reinforcement studied by the use of place conditioning in rat
Mucha, R. F., Van Der Kooy, D., O'Shaughnessy, M., & Bucenieks, P. (1982) · Brain Research · doi:10.1016/0006-8993(82)91123-4 · Cited by 485
Self-citationHandbook of psychopharmacology, vol. 16
Woolf, C. J. (1985) · Pain · doi:10.1016/0304-3959(85)90237-4 · Cited by 365
Bremazocine: A potent, long-acting opiate kappa-agonist
Römer, D., Büscher, H., Hill, R. C., Maurer, R., Petcher, T. J., Welle, H. B. A., Bakel, H. C. C. K., & Akkerman, A. M. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90107-1 · Cited by 315
Mucha, R. F., & Iversen, S. D. (1984) · Psychopharmacology · doi:10.1007/bf00427782 · Cited by 308
Self-citationAttenuation of heroin reward in rats by disruption of the mesolimbic dopamine system
Spyraki, C., Fibiger, H. C., & Phillips, A. G. (1983) · Psychopharmacology · doi:10.1007/bf00427827 · Cited by 307
Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference
Van Der Kooy, D., Mucha, R. F., O'Shaughnessy, M., & Bucenieks, P. (1982) · Brain Research · doi:10.1016/0006-8993(82)91124-6 · Cited by 240
Self-citation
Cited by
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Tzschentke, T. M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00060-4 · Cited by 1,266
Conditioned place preference: what does it add to our preclinical understanding of drug reward?
Bardo, M. T., & Bevins, R. A. (2000) · Psychopharmacology · doi:10.1007/s002130000569 · Cited by 1,241
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,014
Self-citationPsychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857
Self-citationA common neurobiology for pain and pleasure
Leknes, S., & Tracey, I. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2333 · Cited by 784
Endogenous opioid systems and alcohol addiction
Herz, A. (1997) · Psychopharmacology · doi:10.1007/s002130050169 · Cited by 759
Self-citationAlcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
Spanagel, R. (2009) · Physiological Reviews · doi:10.1152/physrev.00013.2008 · Cited by 634
The neurobiology of social play behavior in rats
Vanderschuren, L. J. M. J., Niesink, R. J. M., & Van Pee, J. M. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00020-6 · Cited by 559
Spanagel, R., Herz, A., & Shippenberg, T. S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04963.x · Cited by 539
Self-citationChiara, G. D., & Alan North, R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90062-b · Cited by 543
A unified framework for addiction: Vulnerabilities in the decision process
Redish, A. D., Jensen, S., & Johnson, A. (2008) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0800472x · Cited by 501
Addiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483
Lett, B. T. (1989) · Psychopharmacology · doi:10.1007/bf00451687 · Cited by 477
Neurobiological substrates for the dark side of compulsivity in addiction
Koob, G. F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.043 · Cited by 458
The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family
Mogil, J. S., & Pasternak, G. W. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01502-3 · Cited by 441
The dark side of emotion: the addiction perspective
Koob, G. F. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.044 · Cited by 433
Koob, G. F. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_129 · Cited by 423
Simonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B. P., Maldonado, R., & Kieffer, B. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.886 · Cited by 418
Conditioned place preference using opiate and stimulant drugs: A meta-analysis
Bardo, M. T., Rowlett, J. K., & Harris, M. J. (1995) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)00021-r · Cited by 418
The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse
Wee, S., & Koob, G. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1825-8 · Cited by 398
Addiction is a Reward Deficit and Stress Surfeit Disorder
Koob, G. F. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00072 · Cited by 397
Castro, D. C., & Berridge, K. C. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4458-13.2014 · Cited by 396
(1976) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1976.tb140860.x · Cited by 393
Pharmacological evidence for a motivational role of κ-opioid systems in ethanol dependence
Walker, B. M., & Koob, G. F. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301438 · Cited by 392
Dynorphin and the pathophysiology of drug addiction
Shippenberg, T. S., Zapata, A., & Chefer, V. I. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.011 · Cited by 387
Conditioned taste aversion induced by self-administered drugs: Paradox revisited
Hunt, T., & Amit, Z. (1987) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(87)80005-2 · Cited by 334
Stinus, L., Le Moal, M., & Koob, G. F. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90106-e · Cited by 317
Addiction and Stress: An Allostatic View
Koob, G. F., & Schulkin, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.008 · Cited by 315
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
van Ree, J. M., Gerrits, M. A. F. M., & Vanderschuren, L. J. M. J. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01405-4 · Cited by 303
30 years of dynorphins — New insights on their functions in neuropsychiatric diseases
Schwarzer, C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.006 · Cited by 289
Opiate reward: Sites and substrates
Wise, R. A. (1989) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(89)80021-1 · Cited by 287
Neurochemical mechanisms of the defensive behavior in the dorsal midbrain
Brandão, M. L., Anseloni, V. Z., Pandóssio, J. E., De Araújo, J. E., & Castilho, V. M. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00038-x · Cited by 280
The Dopamine Hypothesis of Drug Addiction: Hypodopaminergic State
Melis, M., Spiga, S., & Diana, M. (2005) · International Review of Neurobiology · doi:10.1016/s0074-7742(05)63005-x · Cited by 273
kappa-Opioid receptor signaling and brain reward function
Bruijnzeel, A. W. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.09.008 · Cited by 214
Shippenberg, T. S., Bals-Kubik, R., & Herz, A. (1987) · Brain Research · doi:10.1016/0006-8993(87)91667-2 · Cited by 166
Self-citationChang, P.-C., Pollema-Mays, S. L., Centeno, M. V., Procissi, D., Contini, M., Baria, A. T., Martina, M., & Apkarian, A. V. (2014) · Pain · doi:10.1016/j.pain.2014.02.019 · Cited by 161
Neurobiology of dysregulated motivational systems in drug addiction
Edwards, S., & Koob, G. F. (2010) · Future Neurology · doi:10.2217/fnl.10.14 · Cited by 157
Development of pharmacotherapies for drug addiction: a Rosetta stone approach
Koob, G. F., Kenneth Lloyd, G., & Mason, B. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2828 · Cited by 154
Nealey, K. A., Smith, A. W., Davis, S. M., Smith, D. G., & Walker, B. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.012 · Cited by 133
Molecular and genetic substrates linking stress and addiction
Briand, L. A., & Blendy, J. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.11.002 · Cited by 125
Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion
Chefer, V. I., Bäckman, C. M., Gigante, E. D., & Shippenberg, T. S. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.171 · Cited by 122
κ-Opioid Receptors within the Nucleus Accumbens Shell Mediate Pair Bond Maintenance
Resendez, S. L., Kuhnmuench, M., Krzywosinski, T., & Aragona, B. J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5779-11.2012 · Cited by 110
“” Here, we demonstrate that blockade of -opioid receptors (known to mediate aversion) (Mucha and Herz, 1985; Pfeiffer et al., 1986), but not -opioid receptors (known to mediate reward and positive hedonics) (Weeks, 1962; Bozarth and Wise, 1981), prevents selective aggression.”
BackgroundHedonic homeostatic dysregulation as a driver of drug-seeking behavior
Koob, G. F. (2008) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2009.04.002 · Cited by 114
Dopamine and opioid systems interact within the nucleus accumbens to maintain monogamous pair bonds
Resendez, S. L., Keyes, P. C., Day, J. J., Hambro, C., Austin, C. J., Maina, F. K., Eidson, L. N., Porter-Stransky, K. A., Nevárez, N., McLean, J. W., et al. (2016) · eLife · doi:10.7554/elife.15325 · Cited by 88
Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol
Anderson, R. I., & Becker, H. C. (2017) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13406 · Cited by 79
κ opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake
Whitfield, T. W., Schlosburg, J. E., Wee, S., Gould, A., George, O., Grant, Y., Zamora-Martinez, E. R., Edwards, S., Crawford, E., Vendruscolo, L. F., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1978-13.2015 · Cited by 75
Nylander, I., Vlaskovska, M., & Terenius, L. (1995) · Psychopharmacology · doi:10.1007/bf02245939 · Cited by 61
Noble, F., & Marie, N. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00742 · Cited by 56
Skoubis, P. D., & Maidment, N. T. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00121-0 · Cited by 54
Walters, C. L., Godfrey, M., Li, X., & Blendy, J. A. (2005) · Brain Research · doi:10.1016/j.brainres.2004.11.013 · Cited by 39
Kelsey, J. E., Verhaak, A. M. S., & Schierberl, K. C. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.008 · Cited by 36
Kim, K.-S., Kim, H., Baek, I.-S., Lee, K.-W., & Han, P.-L. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2143-x · Cited by 31
Metadata
- Authors
- Mucha, R. F., & Herz, A.
- Venue
- Psychopharmacology
- Published
- 1985
- Volume
- 86
- Issue
- 3
- Pages
- 274-280
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1968346138
- Cited by
- 510
- References
- 28
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.